Terms: = Prostate cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954
256 results:
1. The Effect of Treatment Intensification on Other-Cause Mortality in Clear-Cell Metastatic Renal Cell Carcinoma Patients.
Incesu RB; Barletta F; Garcia CC; Scheipner L; Morra S; Baudo A; Assad A; Tian Z; Saad F; Shariat SF; Carmignani L; Longo N; Ahyai S; Chun FKH; Briganti A; Tilki D; Graefen M; Karakiewicz PI
Clin Genitourin Cancer; 2024 Apr; 22(2):420-425. PubMed ID: 38307818
[TBL] [Abstract] [Full Text] [Related]
2. A non-socially-sensitive predictive model of prostate cancer for Asian males with benign prostatic hyperplasia: A multi-site cross-sectional case-control study.
Chang HJ; Moi SH; Chan YJ; Lan TY
PLoS One; 2023; 18(12):e0295608. PubMed ID: 38079423
[TBL] [Abstract] [Full Text] [Related]
3. Discovery of novel flavonoid-based CDK9 degraders for prostate cancer treatment via a PROTAC strategy.
Wu T; Zhang Z; Gong G; Du Z; Xu Y; Yu S; Ma F; Zhang X; Wang Y; Chen H; Wu S; Xu X; Qiu Z; Li Z; Wu H; Bian J; Wang J
Eur J Med Chem; 2023 Nov; 260():115774. PubMed ID: 37672930
[TBL] [Abstract] [Full Text] [Related]
4. Germline Genetic Variants Associated with Somatic TMPRSS2:ERG Fusion Status in prostate cancer: A Genome-Wide Association Study.
Ma C; Wang X; Dai JY; Turman C; Kraft P; Stopsack KH; Loda M; Pettersson A; Mucci LA; Stanford JL; Penney KL
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1436-1443. PubMed ID: 37555839
[TBL] [Abstract] [Full Text] [Related]
5. Measuring cancer burden in prostatic needle core biopsies: simplified assessments outperform complex measurements in assessing outcome: evidence to assist pathologist efficiency and minimize datasets.
Berney DM; Finnegan K; Chu K; Fine SW; Varma M; Cuzick J; Beltran L;
Histopathology; 2023 Jun; 82(7):1021-1028. PubMed ID: 36779238
[TBL] [Abstract] [Full Text] [Related]
6. Targeted silencing of the mcl-1 gene using multi-layered dendrimer-based nanoconstructs achieves efficient tumor regression in xenografted mice models.
Tambe P; Salve R; Choudhary P; Kumar P; Jadhav S; Paknikar KM; Gajbhiye V
Int J Pharm; 2023 Mar; 634():122659. PubMed ID: 36720446
[TBL] [Abstract] [Full Text] [Related]
7. Family History of prostate cancer and Survival Outcomes in the UK Genetic prostate cancer Study.
Brook MN; Ní Raghallaigh H; Govindasami K; Dadaev T; Rageevakumar R; Keating D; Hussain N; Osborne A; Lophatananon A; ; Muir KR; Kote-Jarai Z; Eeles RA
Eur Urol; 2023 Mar; 83(3):257-266. PubMed ID: 36528478
[TBL] [Abstract] [Full Text] [Related]
8. Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in prostate cancer.
Li C; Dou P; Lu X; Guan P; Lin Z; Zhou Y; Lu X; Lin X; Xu G
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012594
[TBL] [Abstract] [Full Text] [Related]
9. Impact of family history on clinicopathological variables and disease progression in Japanese prostate cancer patients undergoing robotic-assisted radical prostatectomy.
Sasaki T; Matsumoto R; Higashi S; Kato M; Masui S; Yoshio Y; Nishikawa K; Inoue T
Int J Urol; 2022 Nov; 29(11):1339-1346. PubMed ID: 36000706
[TBL] [Abstract] [Full Text] [Related]
10. Significance of prostate/pancreatic/skin cancer family history for detecting BRCA2 pathogenic variant careers among patients with breast cancer.
Minoura Y; Takahashi M; Maeda H; Kuwahara S; Tachikawa H; Yamamoto M; Tomioka N; Watanabe K; Sakurai A
Breast Cancer; 2022 Sep; 29(5):808-813. PubMed ID: 35641852
[TBL] [Abstract] [Full Text] [Related]
11. Sulfated Naphthopyrones and Anthraquinones from the Vietnamese Crinoid Comanthus delicata.
Vien LT; Hanh TTH; Quang TH; Thung DC; Cuong NX; Nam NH; Cuong PV; Kiem PV; Minh CV
Chem Pharm Bull (Tokyo); 2022; 70(5):408-412. PubMed ID: 35491198
[TBL] [Abstract] [Full Text] [Related]
12. Targeting of mcl-1 Expression by MiRNA-3614-5p Promotes Cell Apoptosis of Human prostate cancer Cells.
Hsieh YH; Yu FJ; Nassef Y; Liu CJ; Chen YS; Lin CY; Feng JL; Wu MH
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457012
[TBL] [Abstract] [Full Text] [Related]
13. Methylation Subtypes of Primary prostate cancer Predict Poor Prognosis.
Wang X; Jordahl KM; Zhu C; Livingstone J; Rhie SK; Wright JL; Grady WM; Boutros PC; Stanford JL; Dai JY
Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1473-1482. PubMed ID: 35437583
[TBL] [Abstract] [Full Text] [Related]
14. Stem Extract from
Chainumnim S; Saenkham A; Dolsophon K; Chainok K; Suksamrarn S; Tanechpongtamb W
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209099
[TBL] [Abstract] [Full Text] [Related]
15. Pseudo-T2 mapping for normalization of T2-weighted prostate MRI.
Sørland KI; Sunoqrot MRS; Sandsmark E; Langørgen S; Bertilsson H; Trimble CG; Lin G; Selnæs KM; Goa PE; Bathen TF; Elschot M
MAGMA; 2022 Aug; 35(4):573-585. PubMed ID: 35150363
[TBL] [Abstract] [Full Text] [Related]
16. Helix: A Digital Tool to Address Provider Needs for prostate cancer Genetic Testing in Clinical Practice.
Giri VN; Walker A; Gross L; Trabulsi EJ; Lallas CD; Kelly WK; Gomella LG; Fischer C; Loeb S
Clin Genitourin Cancer; 2022 Apr; 20(2):e104-e113. PubMed ID: 35012874
[TBL] [Abstract] [Full Text] [Related]
17. Lucanthone, Autophagy Inhibitor, Enhances the Apoptotic Effects of TRAIL through miR-216a-5p-Mediated DR5 Upregulation and DUB3-Mediated mcl-1 Downregulation.
Yoon JY; Woo SM; Seo SU; Song SR; Lee SG; Kwon TK
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008442
[TBL] [Abstract] [Full Text] [Related]
18. Evasion of cell death: A contributory factor in prostate cancer development and treatment resistance.
Campbell KJ; Leung HY
Cancer Lett; 2021 Nov; 520():213-221. PubMed ID: 34343635
[TBL] [Abstract] [Full Text] [Related]
19. PARP and CDK4/6 Inhibitor Combination Therapy Induces Apoptosis and Suppresses Neuroendocrine Differentiation in prostate cancer.
Wu C; Peng S; Pilié PG; Geng C; Park S; Manyam GC; Lu Y; Yang G; Tang Z; Kondraganti S; Wang D; Hudgens CW; Ledesma DA; Marques-Piubelli ML; Torres-Cabala CA; Curry JL; Troncoso P; Corn PG; Broom BM; Thompson TC
Mol Cancer Ther; 2021 Sep; 20(9):1680-1691. PubMed ID: 34158347
[TBL] [Abstract] [Full Text] [Related]
20. Freehand versus Grid-Based Transperineal prostate Biopsy: A Comparison of Anatomical Region Yield and Complications.
Urkmez A; Demirel C; Altok M; Bathala TK; Shapiro DD; Davis JW
J Urol; 2021 Oct; 206(4):894-902. PubMed ID: 34100650
[TBL] [Abstract] [Full Text] [Related]
[Next]
